Frontage Laboratories and Frontage Clinical Services have unveiled plans to provide full service human radiolabeled Absorption, Metabolism, and Excretion (hAME) study capabilities, subject to receipt of required regulatory approvals.
Frontage Holdings Corporation, a contract research organization (CRO) providing integrated, science-driven research, analytical and development services with presence in both North America and China.